SCHEMBL30234366

SCHEMBL30234366

COCOc1cccc(Br)c1I

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.37
HTR7 P34969 2/20 0.36
HTR1A P08908 1/20 0.36
MAPT P10636 5/20 0.33
L3MBTL1 Q9Y468 4/20 0.33
HPGD P15428 3/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
NPC1 O15118 3/20 0.33
RAB9A P51151 3/20 0.33
CYP2C19 P33261 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
LMNA P02545 2/20 0.33
MAPK1 P28482 1/20 0.33
CHEK1 O14757 1/20 0.32
AURKA O14965 1/20 0.32
DAPK3 O43293 1/20 0.32
JAK2 O60674 1/20 0.32
ABL1 P00519 1/20 0.32
NTRK1 P04629 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23884122 1.00 PTPN1 (0.37) PTPN1HTR7HTR1AMAPTL3MBTL1
SCHEMBL1606856 0.86 PTPN1 (0.42) PTPN1MAPTL3MBTL1HPGDSMN1; SMN2
SCHEMBL2046409 0.81 SMN1; SMN2 (0.44) PTPN1MAPTL3MBTL1HPGDSMN1; SMN2
SCHEMBL9082172 0.81 PTPN1 (0.39) PTPN1HTR7MAPTL3MBTL1HPGD
SCHEMBL29572501 0.80 HTR7 (0.53) HTR7HTR1AMAPTL3MBTL1HPGD
SCHEMBL755670 0.80 HTR7 (0.53) HTR7HTR1AMAPTL3MBTL1HPGD
SCHEMBL6564781 0.79 PTPN1 (0.41) PTPN1HTR7MAPTL3MBTL1HPGD
SCHEMBL6932234 0.79 PTPN1 (0.49) PTPN1HTR1AMAPTL3MBTL1SMN1; SMN2
SCHEMBL17919290 0.79 PTPN1 (0.45) PTPN1HTR7MAPTL3MBTL1HPGD
SCHEMBL4054307 0.78 CA1 (0.46) MAPTL3MBTL1HPGDSMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115916748-A Indole derivatives as alpha-1 antitrypsin modulators for the treatment of alpha-1 antitrypsin deficiency (AATD) 弗特克斯药品有限公司 2023-04-04 CN disclosed
EP-4132908-A1 INDOLE DERIVATIVES AS ALPHA-1 -ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1 -ANTITRYPSIN DEFICIENCY (AATD) Vertex Pharmaceuticals Incorporated (US) 2023-02-15 EP disclosed